We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.31B
1-Year Est. Return
62.02%
This Fund
S&P 500
This Quarter
Est. Return
+19.61%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.63B
AUM Growth
+$411M
(+19%)
Cap. Flow
+$161M
Cap. Flow
% of AUM
6.13%
Top 10 Holdings %
Top 10 Hldgs %
44.92%
Holding
2,471
New
804
Increased
452
Reduced
440
Closed
595
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$13.4M |
| 2 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
+$10.5M |
| 3 |
CISN
Cision Ltd. Ordinary Share
CISN
|
+$10M |
| 4 |
MDCO
Medicines Co
MDCO
|
+$8.78M |
| 5 |
TIF
Tiffany & Co.
TIF
|
+$7.91M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$42.5M |
| 2 |
VSM
Versum Materials, Inc.
VSM
|
+$29.7M |
| 3 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$23.3M |
| 4 |
AABA
Altaba Inc
AABA
|
+$18.8M |
| 5 |
CPE
Callon Petroleum Company
CPE
|
+$17.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.59% |
| 2 | Healthcare | 3.78% |
| 3 | Consumer Discretionary | 3.06% |
| 4 | Communication Services | 2.48% |
| 5 | Real Estate | 2.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Ross Stores
ROST
$81.9B
| $59K | ﹤0.01% |
503
+434
| +629% | +$48.8K |
|
|
MDLA
1277
DELISTED
Medallia, Inc.
MDLA
| $59K | ﹤0.01% |
1,892
-3,641
| -66% | -$108K |
|
1278
CALL
Gilead Sciences
GILD
$165B
| $58K | ﹤0.01% |
+900
| New | +$58.6K |
|
|
HIBB
1279
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $58K | ﹤0.01% |
+2,059
| New | +$52.2K |
|
1280
Flexsteel Industries
FLXS
$311M
| $57K | ﹤0.01% |
2,874
+1,474
| +105% | +$25.7K |
|
1281
Willis Towers Watson
WTW
$32B
| $57K | ﹤0.01% |
282
+228
| +422% | +$43.7K |
|
|
WRK
1282
DELISTED
WestRock Company
WRK
| $57K | ﹤0.01% |
+1,332
| New | +$51.9K |
|
1283
Aspen Aerogels
ASPN
$518M
| $56K | ﹤0.01% |
7,229
+4,232
| +141% | +$29.2K |
|
1284
Greif
GEF
$5.04B
| $56K | ﹤0.01% |
+1,256
| New | +$52K |
|
1285
Intellicheck
IDN
$79.6M
| $56K | ﹤0.01% |
+7,500
| New | +$46.5K |
|
1286
Jack in the Box
JACK
$335M
| $56K | ﹤0.01% |
716
-4,963
| -87% | -$411K |
|
1287
McKesson
MCK
$101B
| $56K | ﹤0.01% |
+403
| New | +$57K |
|
1288
Cincinnati Financial
CINF
$27.1B
| $55K | ﹤0.01% |
+520
| New | +$56.9K |
|
|
GHG
1289
GreenTree Hospitality
GHG
$113M
| $55K | ﹤0.01% |
+5,024
| New | +$54.5K |
|
1290
Jefferies Financial Group
JEF
$13.1B
| $55K | ﹤0.01% |
+2,671
| New | +$50.5K |
|
1291
Nu Skin
NUS
$267M
| $55K | ﹤0.01% |
+1,348
| New | +$55K |
|
1292
TTEC Holdings
TTEC
$124M
| $55K | ﹤0.01% |
+1,400
| New | +$61.3K |
|
1293
Boise Cascade
BCC
$3.02B
| $54K | ﹤0.01% |
+1,475
| New | +$53.5K |
|
1294
Eastman Chemical
EMN
$8.42B
| $54K | ﹤0.01% |
+678
| New | +$52.1K |
|
1295
Empire State Realty Trust
ESRT
$836M
| $54K | ﹤0.01% |
+3,864
| New | +$54.2K |
|
|
FARM
1296
DELISTED
Farmer Brothers
FARM
| $54K | ﹤0.01% |
3,554
-2,191
| -38% | -$32K |
|
1297
Itaú Unibanco
ITUB
$87.5B
| $54K | ﹤0.01% |
+8,070
| New | +$50.6K |
|
1298
Southern Copper
SCCO
$166B
| $54K | ﹤0.01% |
1,379
-4,554
| -77% | -$159K |
|
|
BCOV
1299
DELISTED
Brightcove, Inc.
BCOV
| $54K | ﹤0.01% |
6,219
+759
| +14% | +$7.13K |
|
1300
AstraZeneca
AZN
$250B
| $53K | ﹤0.01% |
534
-6,019
| -92% | -$567K |
|
Similar funds
PFBT
CCP
SP
HCS
SPC
GPCM
MCM
CC
Prelude Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Prelude Capital Management held 2,471 positions worth $2.63B, up 19% from $2.22B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Prelude Capital Management deployed $161M of net new capital in Q4 2019, opening 804 new positions and adding to 452 existing holdings. Its largest new stake was Netflix: 452,870 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 4.6% of assets, down from 6.3% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Callon Petroleum Company, an estimated $17.2M trimmed.
- Prelude Capital Management's largest Q4 2019 buy was Netflix: 452,870 shares worth $14.7M.
- Prelude Capital Management added most to Cision Ltd. Ordinary Share in Q4 2019, an estimated $10M increase.
- Prelude Capital Management's biggest Q4 2019 reduction was Callon Petroleum Company, cutting an estimated $17.2M.
- Prelude Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $42.5M.
- Prelude Capital Management's ten largest holdings make up 45% of its $2.63B portfolio in Q4 2019.
- Prelude Capital Management opened 804 new positions and closed 595 in Q4 2019.
- Prelude Capital Management's portfolio value rose 19% quarter-over-quarter to $2.63B.
Based on Prelude Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.